Murray G. Brown

Cost-effectiveness of disease-modifying therapies in the management of multiple sclerosis for the Medicare population.

Christopher McCabe, Jason Madan, Paul Tappenden, 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

A comparison of health utility measures for the evaluation of multiple sclerosis treatments

J. Fisk, T. J. Murray, I. Sketris, 2004, Journal of Neurology, Neurosurgery & Psychiatry.

Societal Costs of Vascular Cognitive Impairment in Older Adults

J. Fisk, K. Rockwood, H. Merry, 2002, Stroke.

How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?

J. Fisk, T. J. Murray, I. Sketris, 2007, Neurology.

How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?

J. Fisk, T. J. Murray, I. Sketris, 2007, Neurology.